Nazim Isma

Medicine & Life Sciences

1. Venous Thromboembolism 100%
2. Thrombophilia 86%
3. factor V Leiden 59%
4. Venous Thrombosis 53%
5. Percutaneous Coronary Intervention 41%
6. Syncope 40%
7. Anticoagulants 37%
8. von Willebrand Factor 36%
9. Atrial Fibrillation 35%
10. Myocardial Infarction 33%
11. Sweden 32%
12. Epidemiology 30%
13. Dalteparin 28%
14. bivalirudin 27%
15. Mutation 27%
16. Mortality 26%
17. Low Molecular Weight Heparin 26%
18. Ticagrelor 26%
19. Cohort Studies 25%
20. First Labor Stage 24%
21. Orthostatic Hypotension 23%
22. Troponin T 22%
23. Vitamin K 21%
24. Upper Extremity 21%
25. Thromboembolism 21%
26. ST Elevation Myocardial Infarction 20%
27. Hemorrhage 20%
28. Von Willebrand antigen 20%
29. Stroke 19%
30. Acute Coronary Syndrome 18%
31. Heparin 18%
32. Chest Pain 18%
33. Population 18%
34. Hemoglobins 17%
35. Observational Studies 17%
36. Pulmonary Embolism 16%
37. Heart Diseases 16%
38. Recurrence 16%
39. Veins 15%
40. Coronary Vessels 15%
41. Ischemia 14%
42. Incidence 14%
43. Extremities 13%
44. Head 13%
45. Activated Protein C Resistance 13%
46. Fibrinogen 13%
47. Therapeutics 13%
48. Elderly 12%
49. Coronary Artery Disease 12%
50. Lipids 12%